1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.

Clinical trial NCT00345696 · COMPLETED

Trial details

NCT number: NCT00345696
Sponsor: Unidad Integral de Investigación en Oncología S.L.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2006-06-01
Primary completion: 2008-10-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.